Compliance Rate
Compliance Rate
50.0%
Compliant submissions
2
Incompliant submissions
2
Total trials
4
My Organizations' Clinical Trials
Showing 650 of 1308 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/22/23
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 02/15/20
End: 04/09/24
Due: 04/09/25
Phase: N/A
Priority: Normal
Start: 11/10/22
End: 03/01/26
Due: 03/01/27
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 01/29/14
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 11/11/20
End: 04/01/23
Due: 04/01/24
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 05/09/17
Due: 05/09/18
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 06/30/12
Due: 06/30/13
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
Phase: N/A
Priority: Normal
Start: 07/01/14
End: 10/27/15
Due: 10/27/16
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 11/30/20
End: 12/03/21
Due: 12/03/22
Phase: N/A
Priority: Normal
Start: 01/23/17
End: 10/01/19
Due: 10/01/20
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 08/23/22
Due: 08/23/23
Phase: N/A
Priority: Normal
Start: 01/15/20
End: 10/19/21
Due: 10/19/22
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 06/20/18
End: 03/02/20
Due: 03/02/21
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 09/22/21
Due: 09/22/22
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 03/26/18
Due: 03/26/19
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 03/01/20
Due: 03/01/21
Phase: N/A
Priority: Normal
Start: 02/07/17
End: 03/26/23
Due: 03/26/24
Phase: N/A
Priority: Normal
Start: 01/11/23
End: 01/04/24
Due: 01/04/25
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 07/31/13
Due: 07/31/14